Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Redemption of non-convertible debentures
A portion of the fresh issue proceeds is earmarked for the part or full redemption of outstanding non-convertible debentures.
General corporate purposes
The remaining fresh issue proceeds, after funding the objective above and issue expenses, will be used for general corporate purposes.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Archean Chemical Industries Limited is a specialty marine chemicals manufacturer based in India, focused on the production and export of bromine, industrial salt and sulphate of potash. The company operates an integrated manufacturing complex at Hajipur, Gujarat, on the northern edge of the Rann of Kutch brine fields, and was India's largest exporter of bromine and industrial salt by volume in Fiscal 2021. It is also the only domestic manufacturer of sulphate of potash. The company is promoted by Chemikas Speciality LLP together with Ravi Pendurthi and Ranjit Pendurthi, and its registered office is located in Chennai, Tamil Nadu. It serves a global customer base spanning about 13 countries alongside a domestic customer network of roughly 29 clients, exporting bromine and its derivatives, industrial salt and sulphate of potash used across pharmaceuticals, agrochemicals, oil and gas, water treatment and other industrial applications. Archean Chemical Industries has delivered strong revenue and profit growth in the years leading up to its public listing, supported by rising global demand for bromine derivatives and industrial salt and by its position as one of the few integrated marine-chemicals producers of scale in India. Its access to a large brine reserve base and export orientation differentiate it from most domestic specialty chemical peers.
The company raised approximately Rs 658 crore from anchor investors ahead of the public issue, with participation from 42 investors including SBI Mutual Fund, Nippon Life India, ICICI Prudential, HDFC Mutual Fund, Goldman Sachs and DSP Small Cap Fund.
Source: N/A • Analysis provided for informational purposes
Last Updated: Not available
Strengths are not available
Risks are not available
MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.